Accelerating Value-based Healthcare for Patients
Lyfegen has raised €16M across 4 funding rounds from 4 investors, most recently a Series A round in Dec 2024. Based in Basel, Switzerland; founded 2018; active in Healthtech. Data as of 6 Aug 2026.
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2024-12-11 | Series A | €5.4M | aMoon,Other investors,TX Ventures | View deal → |
| 2022-09-21 | Series A | €8.1M | aMoon,APEX Ventures | View deal → |
| 2020-09-01 | Seed | €1.9M | — | View deal → |
| 2019-04-01 | Seed | €671k | — | View deal → |
